JPRN-UMIN000003291
Completed
Phase 3
Occlusive/Stenotic Peripheral artery REvascularization study - OSPREY
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Terumo Corporation
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Terminal illness in whom life expectancy is expected to be less than 3 years. (2\) Patients who are participating in other clinical study of medical device or pharmaceuticals within 3months before registration. (3\) Already participated in this study in the past. (4\) Previously received a bypass surgery, stent implantation or any surgery at SFA or distally. (5\) Scheduled for a staged procedure to treat lesions within the aorta or ipsilateral run\-off vessels after enrollment. (6\) Allergy or experienced an anaphylactic symptom to components of the study device. (7\) Acute or chronic renal failure (serum creatinine 2\.0mg/dL or more) (8\) Advanced calcification or excessive tortuosity at target lesion (9\) Patients who are pregnant or breast\-feeding, or in whom these conditions are possible. (10\) Patients who were judged to be inappropriate for participation in the study due to severe or uncontrolled systemic disease of any condition by the principal investigators/investigators.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Occlusive/Stenotic Peripheral artery REvascularization studY for LONG stentPeripheral arterial disease of lower extremities by a stenotic or occlusive de novo lesion at SFA/PAJPRN-UMIN000006636Terumo Corporation35
Completed
Not Applicable
Angiogenic Therapy Against Peripheral Arterial Disease with bone marrow derived MSC grown in platelet-rich plasmaJPRN-UMIN000021426ational Center for Global Health and Medicine5
Recruiting
Not Applicable
Percutaneous Complete Revascularization Strategies Using Sirolimus Eluting Biodegradable Polymer Coated Stents in Patients Presenting With Acute Coronary Syndromes and Multivessel DiseaseNL-OMON54743Erasmus MC, Universitair Medisch Centrum Rotterdam794
Completed
Not Applicable
Reperfuse Ischemic Vessels with Endovascular Recanalization Device in JAPAN (RIVER JAPAN)Acute Ischemic StrokeJPRN-UMIN000011090Johnson & Johnson K.K. Medical Company50
Completed
Not Applicable
Revascularization by Peripheral Blood Mononuclear Cell TransplantatioCritical limb ischemia due to peripheral artery disease (critical limb ischemia) and Buerger's diseaseJPRN-UMIN000029597Kumamoto University6